Novartis AG (NVS) Financials

NVS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 118.5 billion 79.6 billion
Dec. 31, 2025 115.6 billion 69.0 billion
Sept. 30, 2025 107.3 billion 62.5 billion
June 30, 2025 104.4 billion 62.3 billion

NVS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 2.9 billion 303.0 million
Dec. 31, 2025 1.6 billion 299.0 million
Sept. 30, 2025 5.7 billion 268.0 million
June 30, 2025 6.1 billion 267.0 million

NVS Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 3.2 billion
Dec. 31, 2025 2.4 billion
Sept. 30, 2025 3.9 billion
June 30, 2025 4.0 billion

NVS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 7.0 billion 37.4 billion 1.9 billion
Dec. 31, 2025 11.6 billion 29.6 billion 1.9 billion
Sept. 30, 2025 9.8 billion 22.6 billion 1.9 billion
June 30, 2025 7.0 billion 22.5 billion 1.9 billion

NVS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1.9 billion
Dec. 31, 2025 1.9 billion
Sept. 30, 2025 1.9 billion
June 30, 2025 2.0 billion

NVS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 807.0 million 2.7 billion 3.1 billion -
Dec. 31, 2025 610.9 million 2.8 billion 3.4 billion -
Sept. 30, 2025 831.0 million 2.9 billion 3.3 billion -
June 30, 2025 558.0 million 2.7 billion 3.4 billion 3.4 million

NVS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 13.5 billion 3.5 billion
Dec. 31, 2025 13.3 billion 3.5 billion
Sept. 30, 2025 14.4 billion 3.5 billion
June 30, 2025 14.8 billion 3.3 billion

NVS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NVS

List: Challengers

Price: $154.34

52 week price:
112.34
170.46

Dividend Yield: 2.96%

5-year range yield:
2.96%
4.15%

Forward Dividend Yield: 3.19%

Payout Ratio: 77.24%

Payout Ratio Range:
0.24%
389.86%

Dividend Per Share: 4.77 USD

Earnings Per Share: 6.98 USD

P/E Ratio: 21.00

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Switzerland

Volume: 1.7 million

Ebitda: 2.5 billion

Market Capitalization: 305.1 billion

Average Dividend Frequency: 1

Years Paying Dividends: 30

DGR3: 6.30%

DGR5: 5.29%

DGR10: 4.91%

DGR20: 8.93%

Links: